期刊文献+

动态观察非酒精性脂肪肝大鼠肝脏中大麻素受体的表达

The dynamic expressions of endocannabinoid receptors in livers of rats with non-alcoholic fatty liver disease
下载PDF
导出
摘要 目的:观察大麻素CB1、CB2受体在非酒精性脂肪性肝病(NAFLD)大鼠肝组织中的动态表达,探讨大麻素受体在大鼠NAFLD发病中的作用。方法:利用高脂饮食建立NAFLD大鼠模型,分别在第8、16、24周处死大鼠,HE染色观察肝脏脂肪变、炎症活动和纤维化程度,用免疫组化染色方法观察CB1、CB2受体在NAFLD不同阶段肝组织中的表达。结果:实验大鼠8周呈单纯性脂肪肝改变,16周肝组织弥漫性脂肪变,伴炎性细胞浸润,24周肝脏脂肪肝仍存在,但炎症程度有所减轻,出现程度不同的纤维化。正常大鼠肝脏CB1,CB2受体无明显表达,而在实验组大鼠中的表达均显著增加,CB1受体在第8、24周的表达强于CB2受体。结论:CB1、CB2受体在NAFLD大鼠肝组织中的表达明显增加,提示CB1、CB2受体在肝脏病变过程中发挥重要的作用。 Objective: To investigate the dynamic expressions of endocannabinoid receptors(CB1,CB2) in the livers of rats with non-alcoholic fatty liver disease(NAFLD) and explore the role of endocannabinoid receptors in the pathogenesis of NAFLD in rats.Methods: An experimental rat model of NAFLD was established by feeding rats with high fat diet.The rats were euthanized at the 8,16 and 24 weeks.Hepatic steatosis,inflammation activity and fibrosis degree were observed by routine HE staining.The expression of CB1 and CB2 in the livers were determined by immunohistochemistry at different NAFLD stages.Results: The experimental rats exhibited simple fatty 1iver at 8 weeks,diffuse hepatic steatosis with inflammatory cell infiltration at 16 weeks,and at 24 weeks hepatic steatosis was still present while the degree of inflammation reduced and with different grade of fibrosis.CB1 and CB2 were not expressed in the livers of normal rats,however,the expressions of CB1 and CB2 were significantly increased in the livers of experimental rats.The expression of CB1 was higher than that of CB2 at 8 and 24 weeks.Conclusion: The expression of CB1 and CB2 is significantly increased in the livers of rats with NAFLD,and may play an important role in the pathogenesis of NAFLD.
出处 《南通大学学报(医学版)》 2011年第5期338-340,F0003,共4页 Journal of Nantong University(Medical sciences)
基金 南通大学医学院课题(20008k-10)
关键词 非酒精性脂肪性肝病 大麻素受体 肝脂肪变性 non-alcoholic fatty liver disease cannabinoid receptor hepatic steatosis
  • 相关文献

参考文献7

二级参考文献71

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Maccarrone M, Finazzi-Agro A.The endocannabinoid system. anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ, 2003, 10: 946-955. 被引量:1
  • 3Ros J, Claria J, To-Figueras J, et al. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology, 2002, 122: 85-93. 被引量:1
  • 4Oben JA, Yang S, Lin H, et al. Norepinephrine and neuropeptide Y promote proliferation and collagen gene expression of hepatic myofibroblastic stellate cells. Biochem Biophys Res Commun, 2003, 302: 685-690. 被引量:1
  • 5Sato M, Suzuki S, Senoo H. Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct Funct, 2003, 28: 105-112. 被引量:1
  • 6Issa R, Zhou X, Constandinou CM, et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology, 2004, 126: 1795- 1808. 被引量:1
  • 7Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science,1992,258:1946-1949. 被引量:1
  • 8Piomelli D, Giuffrida A, Calignano A, et al. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci, 2000, 21: 218-224. 被引量:1
  • 9Batkai S, Jarai Z, Wagner JA, et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med, 2001, 7: 827-832. 被引量:1
  • 10Siegmund SV, Uchinami H, Osawa Y, et al. Anandamide induces necrosis in primary hepatic stellate cells. Hepatology, 2005, 41: 1085- 1095. 被引量:1

共引文献1520

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部